NRC Health (NRC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 35.02M USD | Liabilities, Current |
| Cash and equivalents | 3.33M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 9.32M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $35.02M | $3.33M | (m) | $9.32M | (m) | (m) |
| 2026-03-31 | (m) | $38.47M | $2.55M | (m) | $10.83M | (m) | (m) |
| 2025-12-31 | (m) | $36.62M | $4.14M | (m) | $11.11M | (m) | (m) |
| 2025-09-30 | (m) | $38.57M | $2.22M | (m) | $12.75M | (m) | (m) |
| 2025-06-30 | (m) | $35.93M | $5.27M | (m) | $12.42M | (m) | (m) |
| 2025-03-31 | (m) | $37.77M | $2.50M | (m) | $11.33M | (m) | (m) |
| 2024-12-31 | (m) | $35.86M | $4.23M | (m) | $11.05M | (m) | (m) |
| 2024-09-30 | (m) | $44.28M | $3.46M | (m) | $11.06M | (m) | (m) |
| 2024-06-30 | (m) | $45.73M | $485.00K | (m) | $10.06M | (m) | (m) |
| 2024-03-31 | (m) | $48.85M | $1.70M | (m) | $11.13M | (m) | (m) |
| 2023-12-31 | (m) | $36.20M | $6.65M | (m) | $12.38M | (m) | (m) |
| 2023-09-30 | (m) | $40.80M | $3.83M | (m) | $14.47M | (m) | (m) |
| 2023-06-30 | (m) | $33.74M | $22.50M | (m) | $11.89M | (m) | (m) |
| 2023-03-31 | (m) | $36.11M | $23.72M | (m) | $14.22M | (m) | (m) |
| 2022-12-31 | (m) | $33.42M | $25.03M | (m) | $14.46M | (m) | (m) |
| 2022-09-30 | (m) | $41.08M | $28.39M | (m) | $15.38M | (m) | (m) |
| 2022-06-30 | (m) | $39.59M | $32.97M | (m) | $13.11M | (m) | (m) |
| 2022-03-31 | (m) | $41.57M | $47.29M | (m) | $15.91M | (m) | (m) |
| 2021-12-31 | (m) | $40.39M | $54.36M | (m) | $13.73M | (m) | (m) |
| 2021-09-30 | (m) | $39.17M | $52.48M | (m) | $16.26M | (m) | (m) |
| 2021-06-30 | (m) | $39.98M | $48.90M | (m) | $14.16M | (m) | (m) |
| 2021-03-31 | (m) | $36.94M | $43.45M | (m) | $14.30M | (m) | (m) |
| 2020-12-31 | (m) | $31.68M | $34.69M | (m) | $13.92M | (m) | (m) |
| 2020-09-30 | (m) | $32.07M | $21.86M | (m) | $17.43M | (m) | (m) |
| 2020-06-30 | (m) | $32.27M | $11.96M | (m) | $19.88M | (m) | (m) |
| 2020-03-31 | (m) | $39.88M | $10.02M | (m) | $17.40M | (m) | (m) |
| 2019-12-31 | (m) | $38.16M | $13.52M | (m) | $11.64M | (m) | (m) |
| 2019-09-30 | (m) | $38.31M | $8.36M | (m) | $15.31M | (m) | (m) |
| 2019-06-30 | (m) | $37.08M | $4.02M | (m) | $15.09M | (m) | (m) |
| 2019-03-31 | (m) | $39.24M | $2.64M | (m) | $15.89M | (m) | (m) |
| 2018-12-31 | (m) | $47.11M | $12.99M | (m) | $11.92M | (m) | (m) |
| 2018-09-30 | (m) | $35.44M | $7.27M | (m) | $16.54M | (m) | (m) |
| 2018-06-30 | (m) | $32.92M | $6.70M | (m) | $10.69M | (m) | (m) |
| 2018-03-31 | (m) | $29.48M | $35.48M | (m) | $14.31M | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $14.67M | (m) | (m) |
| 2017-12-31 | (m) | $32.31M | $34.73M | (m) | $13.34M | (m) | (m) |
| 2017-09-30 | (m) | $34.17M | $35.75M | (m) | $13.59M | (m) | (m) |
| 2017-06-30 | (m) | $30.85M | $31.63M | (m) | $13.14M | (m) | (m) |
| 2017-03-31 | (m) | $34.35M | $34.66M | (m) | $13.52M | (m) | (m) |
| 2016-12-31 | (m) | $31.51M | $33.02M | (m) | $10.86M | (m) | (m) |
| 2016-09-30 | (m) | $31.13M | $28.88M | (m) | $14.12M | (m) | (m) |
| 2016-06-30 | (m) | $29.27M | $27.19M | (m) | $11.07M | (m) | (m) |
| 2016-03-31 | (m) | $32.52M | $25.37M | (m) | $14.10M | (m) | (m) |
| 2015-12-31 | (m) | $44.17M | $42.15M | (m) | $9.81M | (m) | (m) |
| 2015-09-30 | (m) | $31.58M | $37.58M | (m) | $12.89M | (m) | (m) |
| 2015-06-30 | (m) | $29.28M | $40.55M | (m) | $10.27M | (m) | (m) |
| 2015-03-31 | (m) | $27.59M | $37.01M | (m) | $11.80M | (m) | (m) |
| 2014-12-31 | (m) | $27.93M | $40.04M | (m) | $8.12M | (m) | (m) |
| 2014-09-30 | (m) | $26.99M | $39.06M | (m) | $10.92M | (m) | (m) |
| 2014-06-30 | (m) | $25.29M | $31.54M | (m) | $11.45M | (m) | (m) |
| 2014-03-31 | (m) | $23.94M | $26.45M | (m) | $12.05M | (m) | (m) |
| 2013-12-31 | (m) | $23.69M | $22.09M | (m) | $11.04M | (m) | (m) |
| 2013-09-30 | (m) | $26.13M | $18.93M | (m) | $11.38M | (m) | (m) |
| 2013-06-30 | (m) | $24.74M | $10.80M | (m) | $14.52M | (m) | (m) |
| 2013-03-31 | (m) | $35.75M | $9.23M | (m) | $14.38M | (m) | (m) |
| 2012-12-31 | (m) | $35.30M | $8.29M | (m) | $12.12M | (m) | (m) |
| 2012-09-30 | (m) | $37.69M | $15.03M | (m) | $14.21M | (m) | (m) |
| 2012-06-30 | (m) | $25.27M | $11.17M | (m) | $13.05M | (m) | (m) |
| 2012-03-31 | (m) | $24.42M | $7.87M | (m) | $13.58M | (m) | (m) |
| 2011-12-31 | (m) | $24.40M | $8.08M | (m) | $11.19M | (m) | (m) |
| 2011-09-30 | (m) | $26.66M | $6.22M | (m) | $12.28M | (m) | (m) |
| 2011-06-30 | (m) | $27.15M | $4.46M | (m) | $11.59M | (m) | (m) |
| 2011-03-31 | (m) | (m) | $3.32M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $26.15M | $3.52M | (m) | $9.17M | (m) | (m) |
| 2010-09-30 | (m) | (m) | $3.19M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $7.24M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $2.51M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $1.11M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |